Thiazolidinediones and type 2 diabetes: new drugs for an old disease

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Medical Journal of Australia

• Publication date

  2002-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.5694/j.1326-5377.2002.tb04461.xPMID 12041635
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pioglitazone

  2012cited by this paper
• Hepatocellular injury in a patient receiving pioglitazone.

  2001cited by this paper
• Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes.

  2001cited by this paper
• New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers.

  2001cited by this paper
• A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes.

  2001cited by this paper
• Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.

  2001cited by this paper
• Nonhypoglycemic Effects of Thiazolidinediones

  2001cited by this paper
• Lessons from the glitazones: a story of drug development.

  2001cited by this paper
• The rise and fall of troglitazone.

  2000cited by this paper
• Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.

  2000cited by this paper
• Addition of low‐dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients

  2000cited by this paper
• Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists.

  2000cited by this paper
• Thiazolidinediones: an update.

  2000cited by this paper
• Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

  2000cited by this paper
• Hepatic Failure in a Patient Taking Rosiglitazone

  2000cited by this paper
• Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group.

  2000cited by this paper
• New approaches in the treatment of type 2 diabetes.

  2000cited by this paper
• Hepatocellular Injury in a Patient Receiving Rosiglitazone: A Case Report

  2000cited by this paper
• Treatment of insulin resistance with peroxisome proliferator–activated receptor γ agonists

  2000cited by this paper
• A comparison in a clinical setting of the efficacy and side effects of three thiazolidinediones.

  2000cited by this paper
• Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitus

  2000cited by this paper
• Rosiglitazone toxicity.

  2000cited by this paper
• Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with Type II diabetes

  2000cited by this paper
• The rise and fall of troglitazone

  2000cited by this paper
• Pharmacologic Therapy for Type 2 Diabetes Mellitus

  1999cited by this paper
• Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

  1999cited by this paper
• Glycemic Control with Diet, Sulfonylurea, Metformin, or Insulin in Patients with Type 2 Diabetes Mellitus: Progressive Requirement for Multiple Therapies (UKPDS 49)

  1999cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.

  1997cited by this paper
• Relationship between lactate dehydrogenase and myeloperoxidase levels in human gingival crevicular fluid and clinical and microbial measurements.

  1988cited by this paper
• Role of Insulin Resistance in Human Disease

  1988cited by this paper
• Banting lecture 1988. Role of insulin resistance in human disease.

  1988cited by this paper
• Drugs

  1967cited by this paper
• New drugs; old drugs.

  1954cited by this paper

• Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights

  2023cites this paper
• Efficacy of 3 months of additional pioglitazone treatment in type 2 diabetes patients with alcoholic fatty liver disease

  2023cites this paper
• Tobacco heating system has less impact on bone metabolism than cigarette smoke.

  2023cites this paper
• Pathophysiological Role of Microglial Activation Induced by Blood-Borne Proteins in Alzheimer’s Disease

  2023cites this paper
• Combination of behavioral therapy and varenicline for smoking cessation: Time to beat nicotine

  2022cites this paper
• Electronic Cigarettes or Vaping: Are There Any Differences in the Profiles, Use and Perceptions between a Developed and aDeveloping Country?

  2022cites this paper
• The Effect Of Smoking On Liver Enzymes And Its Functions

  2022cites this paper
• A new insight into the treatment of diabetes by means of pan PPAR agonists

  2022cites this paper
• A systematic review of group therapy programs for smoking cessation in Asian countries

  2021cites this paper
• Application of nano/microencapsulated ingredients in chewing gum

  2021cites this paper
• A review of tobacco abuse and its epidemiological consequences

  2021cites this paper
• Dichloromethane extract of Potentilla fulgens wall. Ex. Sims ameliorates alloxan-induced oxidative stress and inflammatory responses in mice

  2021influential citation
• Electronic cigarettes’ withdrawal severity symptoms among users during intermittent fasting: a cross-sectional study

  2021cites this paper
• The Era of E-Cigarettes: A Cross-Sectional Study of Vaping Preferences, Reasons for Use and Withdrawal Symptoms Among Current E-Cigarette Users in the United Arab Emirates

  2021cites this paper
• Pharmacotherapy based on medical genetics for smoking cessation

  2021cites this paper
• Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS)

  2020cites this paper
• The Effect of Breathing Exercise on Nicotine Withdrawal Symptoms, Cigarette Cravings, and Affect.

  2020cites this paper
• Assessment of Nicotine Dependence, Cotinine Level and Carbon Monoxide Levels among Tobacco Users Employed in Private Automobile Companies in Chennai

  2020cites this paper
• Neuropharmacology of nicotine dependence

  2020cites this paper
• Pharmacotherapeutic Approaches in Tobacco Cessation and its Challenges: A Review

  2020influential citation
• Selective Expression of Nicotinic Receptor Sub-unit mRNA in Early Human Fetal Forebrain

  2020cites this paper
• How Do We Treat Pregnancy-Related Venous Thromboembolism?

  2019cites this paper
• Systematic review of toxicity removal by advanced wastewater treatment technologies via ozonation and activated carbon.

  2019cites this paper
• Design, synthesis, biological evaluation and molecular docking studies of novel 3-substituted-5-[(indol-3-yl)methylene]-thiazolidine-2,4-dione derivatives

  2018cites this paper
• Nursing Intervention Practices for Smoking Cessation: A Large Survey in Hong Kong

  2018cites this paper
• DEVASTATING DEPRESSION OF YOUTH AND ITS REMEDIAL DRUG: A REVIEW

  2018cites this paper
• A review of interventions for smoking cessation

  2017cites this paper
• A Narrative Review of Smoking Cessation Practices in Jordan

  2017cites this paper
• The effectiveness of naltrexone combined with current smoking cessation medication to attenuate post smoking cessation weight gain: a literature review

  2017cites this paper
• The role of brain PPAR[gamma] in regulation of energy balance and glucose homeostasis

  2017cites this paper
• Sleep, health behaviors, and behavioral interventions: Reducing the risk of cardiovascular disease in adults

  2017cites this paper
• Prevention, early intervention, and harm reduction of substance use in adolescents

  2017cites this paper
• Temporal Trends of Psychosociobehavioral Factors Underlying Tobacco Use: A Semi-Automated Exploratory Analysis of Peer-to-Peer Communication in a Health-Related Online Community

  2017cites this paper
• Targeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic Drugs

  2017cites this paper
• Nicotine replacement therapy and varenicline: A cohort study in low-income region (Monastir, Tunisia)

  2017cites this paper
• Use of nicotine replacement therapy in young people entering custody in New South Wales, Australia

  2017cites this paper
• Alte racio ne s me tabó licas e infe cció n po r e l virus de la inmuno de ficie ncia humana

  2016cites this paper
• THERAPEUTIC USES OF DEPENDENCE CAUSING AGENTS: THE PAST AND THE PRESENT Review Article

  2016cites this paper
• Application of a pharmacokinetic/pharmacogenetic approach to assess the nicotine metabolic profile of smokers in the real-life setting.

  2016cites this paper
• Tobacco Use Cessation and Prevention - A Review.

  2016cites this paper
• Evaluation of Antioxidant Activity, Total Phenolic and Nicotine Contents of 15 Thai Herbs

  2016cites this paper
• Smoking-Related Behaviors and Effectiveness of Smoking Cessation Therapy Among Prisoners and Prison Staff

  2016cites this paper
• Role of Oral Antidiabetic Agents in Type-2 Diabetes Mellitus Patients

  2016cites this paper
• Non-Pharmacological Management of Chronic Obstructive Pulmonary Disease

  2015cites this paper
• Type 2 diabetes mellitus: limitations of conventional therapies and intervention with nucleic acid-based therapeutics.

  2015cites this paper
• Untersuchungen zur Expression von Kernrezeptoren und HLA-G in Plazenten von Patientinnen mit Gestationsdiabetes

  2015cites this paper
• The Egyptian Society of Chest Diseases and Tuberculosis Egyptian Journal of Chest Diseases and Tuberculosis

  2015cites this paper
• Seizure in a patient on Wellbutrin: a case report -

  2015cites this paper
• Ascorbic Acid ameliorates nicotine exposure induced impaired spatial memory performances in rats.

  2014cites this paper
• Insulin secreting and alpha-glucosidase inhibitory activity of hexane extract of Annona squamosa Linn. in streptozotocin (STZ) induced diabetic rats.

  2014cites this paper
• Peroxisome proliferator-activated receptor-gamma (PPARγ) is down regulated in trophoblast cells of gestational diabetes mellitus (GDM) and in trophoblast tumour cells BeWo in vitro after stimulation with PPARγ agonists

  2014cites this paper
• Life Gain in Italian Smokers Who Quit

  2014cites this paper
• Safety, Tolerability, and Pharmacokinetics of E3030, a Novel Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist, in Healthy Japanese Male Subjects

  2014cites this paper
• A Multifactoral Analysis of 1452 Patients for Smoking Sensation. An Outpatient Lab Experience

  2014cites this paper
• Induced fit docking, pharmacophore modeling, and molecular dynamic simulations on thiazolidinedione derivatives to explore key interactions with Tyr48 in polyol pathway

  2014cites this paper
• New Anticoagulants and Antiplatelet Agents: A Primer for the Clinical Gastroenterologist

  2014cites this paper
• [Fundamental bases of search of medicines for therapy of a diabetes mellitus type 2].

  2013cites this paper
• Evaluation of hypoglycaemic and hypolipidemic activities of Globularin isolated from Globularia alypum L. in normal and streptozotocin-induced diabetic rats

  2013cites this paper
• Adjusting serum urate level by affecting membrane transporters involved in the disposition of urate

  2013cites this paper
• An Open Label Study investigating the Efficacy of Hypericum perforatum Special Extract (ZE117), Nicotine Patches and Combination (ZE117)/ Nicotine Patches for Smoking Cessation

  2013cites this paper
• Nicotine-, tobacco particulate matter- and methamphetamine-produced locomotor sensitisation in rats

  2013cites this paper
• In vitro reporter gene assays for assessment of PPAR- and Nrf2-mediated health effects of tomato and its bioactive constituents

  2013cites this paper
• The Neurocognitive Effects of Hypericum perforatum Special Extract (Ze 117) during Smoking Cessation

  2013cites this paper
• Nicotine vaccines to treat tobacco dependence

  2013cites this paper
• Second-Hand Tobacco Smoke and Cardiovascular Disease Risk: An Epidemiological Review

  2013cites this paper
• 5-Arylidenethioxothiazolidinones as inhibitors of tyrosyl-DNA phosphodiesterase I.

  2012cites this paper
• Atomoxetine treatment for nicotine withdrawal: a pilot double-blind, placebo-controlled, fixed-dose study in adult smokers

  2012cites this paper
• Use of nicotine replacement therapy among Canadian youth: data from the 2006-2007 National Youth Smoking Survey.

  2011cites this paper
• S-oxidation of thiazolidinedione with hydrogen peroxide, peroxynitrous acid, and C4a-hydroperoxyflavin: a theoretical study.

  2011cites this paper
• Effect of in utero and lactational nicotine exposure on the male reproductive tract in peripubertal and adult rats.

  2011cites this paper
• CHEWING GUM: A MODERN ERA OF DRUG DELIVERY

  2011cites this paper
• The molecular genetics of insulin secretion and signalling

  2011cites this paper
• Stable reporter cell lines for peroxisome proliferator-activated receptor γ (PPARγ)-mediated modulation of gene expression.

  2011cites this paper
• Characterization of Nicotine Replacement Therapy Use by Canadian Youths in Grades 9 – 12

  2011cites this paper
• Smoking Cessation Intervention: An Evidence-Based Approach

  2010cites this paper
• Long-Term Consequences of Fetal and Neonatal Nicotine Exposure: A Critical Review

  2010cites this paper
• Therapy of Diabetes Mellitus Using Experimental Animal Models

  2010cites this paper
• The COPD-X plan

  2010cites this paper
• EXPERIMENTAL ANIMAL MODELS OF DIABETES MELLITUS AND THEIR ROLE IN DEVELOPMENT OF THERAPEUTIC AGENTS

  2010cites this paper
• New findings on nicotine addiction and treatment.

  2009cites this paper
• Tobacco use and measuring nicotine dependence among urban Indigenous pregnant women

  2009cites this paper
• Relationship between cigarette use and mood/anxiety disorders among pregnant methadone-maintained patients.

  2009cites this paper
• Pharmacological and gene modification-based models for studying the impact of perinatal metabolic disturbances in adult life.

  2009cites this paper
• Effectiveness and tolerability of rosiglitazone on insulin resistance and body composition in nondiabetic Thai patients undergoing continuous ambulatory peritoneal dialysis: A 12-week pilot study.

  2009cites this paper
• Weight gain after smoking cessation.

  2009cites this paper
• Synthesis and antihyperglycemic activity of 2-(substituted phenyl)-3-{[4-(1-naphthyl)-1,3-thiazol-2-yl] amino}-4-oxo-1,3-thiazolidin-5-ylacetic acid derivatives.

  2009cites this paper
• CoMFA and CoMSIA analysis of 2,4-thiazolidinediones derivatives as aldose reductase inhibitors

  2009cites this paper
• Nicotinic receptor ligands reduce ethanol intake by high alcohol-drinking HAD-2 rats.

  2009cites this paper
• MMP/ TIMP balance is modulated in vitro by 15dPGJ2 in fetuses and placentas from diabetic rats

  2009cites this paper
• Cost–effectiveness of varenicline for smoking cessation

  2009cites this paper
• La réduction tabagique à la maison d’arrêt de Paris–La Santé

  2008cites this paper
• Formulation and hypoglycemic activity of pioglitazone-cyclodextrin inclusion complexes.

  2008cites this paper
• Drug Class Review: Thiazolidinediones: Final Report Update 1

  2008cites this paper
• Rosiglitazone and delayed onset of proliferative diabetic retinopathy.

  2008cites this paper
• Social factors, psychopathology, and maternal smoking during pregnancy.

  2008cites this paper
• Drug Discoveries & Therapeutics

  2008influential citation
• Smoking cessation : tips for improving success rates P

  2008cites this paper
• Severe hyponatremia due to rosiglitazone use in an elderly woman with diabetes mellitus: a rare cause of syndrome of inappropriate antidiuretic hormone secretion.

  2008cites this paper
• Disrupting Nicotine Reinforcement

  2008cites this paper
• Type 2 Diabetes in Children and Adolescents: Treatment

  2007cites this paper